Evidence map›Paper›PMID 26310854›Full record

ArticleEnvironmental health : a global access science source2015

The associations between daily spring pollen counts, over-the-counter allergy medication sales, and asthma syndrome emergency department visits in New York City, 2002-2012.

Kazuhiko Ito, Kate R Weinberger, Guy S Robinson, Perry E Sheffield, Ramona Lall, Robert Mathes, Zev Ross, Patrick L Kinney, Thomas D Matte

Abstract read
In one paragraph

Article in Environmental health : a global access science source, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Interventions for autumn exacerbations of asthma in children.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Article
  5. Efficacy and safety of the tree sublingual immunotherapy tablet in the subpopulation of Canadian children with allergic rhinitis and/or conjunctivitis: phase III trial results.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A Review of the Respiratory Health Burden Attributable to Short-Term Exposure to Pollen.International journal of environmental research and public health · 2022
    Review
  17. Adaptations to the RVA Breathes clinical trial due to the COVID-19 pandemic.Contemporary clinical trials communications · 2021
    Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kazuhiko ItoNew York City Department of Health and Mental Hygiene, Bureau of Environmental Surveillance and Policy, New York, NY, 10013, USA. kito1@health.nyc.gov.
Kate R WeinbergerDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, 10032-3727, USA. krw2114@cumc.columbia.edu.
Guy S RobinsonLouis Calder Center, Biological Field Station, Fordham University, Armonk, New York, NY, 10504-1104, USA. grobinson@fordham.edu.
Perry E SheffieldDepartments of Pediatrics and Preventive Medicine, Mount Sinai School of Medicine, 1 Gustave L. Levy Pl., Box 1512, New York, NY, 10029, USA. perry.sheffield@mssm.edu.
Ramona LallNew York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, NY, 11101, USA. rlall@health.nyc.gov.
Robert MathesNew York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, NY, 11101, USA. rmathes@health.nyc.gov.
Zev RossZevRoss Spatial Analysis, Ithaca, NY, 14850, USA. zev@zevross.com.
Patrick L KinneyDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, 10032-3727, USA. plk3@cumc.columbia.edu.
Thomas D MatteNew York City Department of Health and Mental Hygiene, Bureau of Environmental Surveillance and Policy, New York, NY, 10013, USA. tmatte@health.nyc.gov.

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ami R Zota · 1998 to 2026
$44.7M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
The Mount Sinai Transdisciplinary Center on Early Environmental ExposuresP30ES023515 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Maria Jose Rosa · 2014 to 2026
$21.3M
Supplemental Training in Making Data FAIR and AI/ML ReadyT32ES007322 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Pam R Factor-Litvak, Allison Kupsco · 2000 to 2026
$12.1M
Research Training Program in Pediatric ExposomicsT32HD049311 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KECIA Nicole CARROLL, Robert O Wright · 2007 to 2026
$7.4M
Interdisciplinary Training in Climate and HealthT32ES023770 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHAMAN, JEFFREY L · 2014 to 2019
$1.5M
Prenatal Pollution, Stress and Maternal-child Health: Role of ImmunomodulationK23ES024127 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SHEFFIELD, PERRY ELIZABETH · 2014 to 2018
$832k
NICHD NIH HHS T32 HD049311NICHD NIH HHS T32HD049311NIEHS NIH HHS K23 ES024127NIEHS NIH HHS K23ES024127NIEHS NIH HHS P30 ES000260NIEHS NIH HHS P30-ES00260NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P30 ES023515NIEHS NIH HHS T32 ES007322NIEHS NIH HHS T32ES007322NIEHS NIH HHS T32 ES023770PHS HHS 200-2009-31909-003
6 · The paper itself

Abstract

backgroundMany types of tree pollen trigger seasonal allergic illness, but their population-level impacts on allergy and asthma morbidity are not well established, likely due to the paucity of long records of daily pollen data that allow analysis of multi-day effects. Our objective in this study was therefore to determine the impacts of individual spring tree pollen types on over-the-counter allergy medication sales and asthma emergency department (ED) visits.

methodsNine clinically-relevant spring tree pollen genera (elm, poplar, maple, birch, beech, ash, sycamore/London planetree, oak, and hickory) measured in Armonk, NY, were analyzed for their associations with over-the-counter allergy medication sales and daily asthma syndrome ED visits from patients' chief complaints or diagnosis codes in New York City during March 1st through June 10th, 2002-2012. Multi-day impacts of pollen on the outcomes (0-3 days and 0-7 days for the medication sales and ED visits, respectively) were estimated using a distributed lag Poisson time-series model adjusting for temporal trends, day-of-week, weather, and air pollution. For asthma syndrome ED visits, age groups were also analyzed. Year-to-year variation in the average peak dates and the 10th-to-90th percentile duration between pollen and the outcomes were also examined with Spearman's rank correlation.

resultsMid-spring pollen types (maple, birch, beech, ash, oak, and sycamore/London planetree) showed the strongest significant associations with both outcomes, with cumulative rate ratios up to 2.0 per 0-to-98th percentile pollen increase (e.g., 1.9 [95% CI: 1.7, 2.1] and 1.7 [95% CI: 1.5, 1.9] for the medication sales and ED visits, respectively, for ash). Lagged associations were longer for asthma syndrome ED visits than for the medication sales. Associations were strongest in children (ages 5-17; e.g., a cumulative rate ratio of 2.6 [95% CI: 2.1, 3.1] per 0-to-98th percentile increase in ash). The average peak dates and durations of some of these mid-spring pollen types were also associated with those of the outcomes.

conclusionsTree pollen peaking in mid-spring exhibit substantive impacts on allergy, and asthma exacerbations, particularly in children. Given the narrow time window of these pollen peak occurrences, public health and clinical approaches to anticipate and reduce allergy/asthma exacerbation should be developed.

Indexed as

AdolescentAdultAgedAged, 80 and overAllergensAsthmaChildChild, PreschoolEmergency Service, HospitalFemaleHumansHypersensitivityInfantInfant, NewbornMaleMiddle AgedAllergensMulti-Ingredient Cold, Flu, and Allergy MedicationsNonprescription Drugs

Identifiers

PMID26310854
PMCPMC4549916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.